July 12, 2014 5:26 PM ET

Biotechnology

Company Overview of Orthobond Corp.

Executive Profile

Gregory E. Lutz M.D.

Chief Medical Advisor for Spine Medicine, BioRestorative Therapies, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships
----

Background

Dr. Gregory E. Lutz, M.D. has been the Chief Medical Advisor for Spine Medicine at BioRestorative Therapies, Inc. since March 3, 2014. Dr. Lutz is responsible for advancing the BioRestorative's brtxDISC(TM) Program including preparing the Company's Investigational New Drug/Investigational Device Exemption application with the U.S. Food and Drug Administration (FDA). In addition, Dr. Lutz leads the efforts to design the trial protocol, identify trial sites and assist ...

Corporate Headquarters

675 US Highway 1
North Brunswick, New Jersey 08902

United States

Phone: 732-729-6235
Fax: 732-745-7270

Board Members Memberships

Trustee
Co-founder, Chairman of The Board and Chief Marketing Officer

Education

MD
Georgetown University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Dominick C. Colangelo Esq.Chief Executive Officer, President, Chief Accounting Officer, Treasurer and Director
Aastrom Biosciences, Inc.
$358.3K
Gil Van Bokkelen Ph.D.Co-Founder, Chairman and Chief Executive Officer
Athersys, Inc.
$568.8K
Michael D. West Ph.D.Chief Executive Officer, President and Director
BioTime, Inc.
$745.3K
Martin M. McGlynn Chief Executive Officer, President, Director, Member of Strategic Transactions Committee, Chief Executive Officer of StemCells California Inc and President of StemCells California Inc
StemCells Inc.
$835.8K
Steven A. Victor M.D.Chairman of the Board, Chief Executive Officer, President, Principal Accounting Officer, Treasurer and Secretary
IntelliCell BioSciences, Inc.
$275.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Orthobond Corp., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.